RBC on argenx SE (ARGX): 'Vyvgart Hits in snMG, TAM Likely to Be Expanded by an Additional 11k Patients'
Tweet Send to a Friend
RBC Capital analyst Luca Issi reiterated an Outperform rating and $850.00 price target on argenx SE (NASDAQ: ARGX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
